Kalbe (Kalbe Farma)

CDMO

Indonesia

https://www.kalbe.co.id/

Is this your company? Claim this profile

Drug Product

Company Overview

About

Kalbe (Kalbe Farma) is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Formulation Development, Process Development, Scale-up

Therapeutic Areas

Immunology

Rheumatology

Quick Facts

HQ:Indonesia

Founded:2017

Employees:708

Capabilities & Services

Core Capabilities

Peptide Synthesis
Small Molecule API
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Inhalation

Containment Capabilities

BSL-2 (Biosafety Level 2)

Production Scales

Phase III Clinical Trials

Commercial Scale

Clinical

Markets Served

Europe

Regulatory Approvals

Drug Approval 54XXFX

EMA · #APR-YG13ANH3 · 2018-09-01

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-OZOB394M

Issued: 2020-09-09

Expires: 2025-01-25

Health Canada GMP

Health Canada

Cert #: CERT-3PAKQ4VQ

Issued: 2020-11-20

Expires: 2025-01-28

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Kalbe (Kalbe Farma)

Kalbe (Kalbe Farma) is headquartered in Indonesia.
Kalbe (Kalbe Farma) was founded in 2017.
Kalbe (Kalbe Farma) has 708 employees.
Kalbe (Kalbe Farma)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

Find CDMOs like Kalbe (Kalbe Farma)

Directory pages this company appears in, each with the full list of matching manufacturers.

Small Molecule API CDMOs Formulation Development CDMOs Inhalation CDMOs BSL-2 (Biosafety Level 2) CDMOs